Cargando…
Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells
BACKGROUND: Accumulating evidence demonstrates that the Urokinase Receptor (uPAR) regulates tumor cell migration through its assembly in composite regulatory units with transmembrane receptors, and uPAR(88–92) is the minimal sequence required to induce cell motility through the Formyl Peptide Recept...
Autores principales: | Ragone, Concetta, Minopoli, Michele, Ingangi, Vincenzo, Botti, Giovanni, Fratangelo, Federica, Pessi, Antonello, Stoppelli, Maria Patrizia, Ascierto, Paolo Antonio, Ciliberto, Gennaro, Motti, Maria Letizia, Carriero, Maria Vincenza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721612/ https://www.ncbi.nlm.nih.gov/pubmed/29216889 http://dx.doi.org/10.1186/s13046-017-0650-x |
Ejemplares similares
-
Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity
por: Minopoli, Michele, et al.
Publicado: (2019) -
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas
por: Carriero, Maria Vincenza, et al.
Publicado: (2017) -
Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion
por: Minopoli, Michele, et al.
Publicado: (2019) -
Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells
por: Ingangi, Vincenzo, et al.
Publicado: (2019) -
The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells
por: Ingangi, Vincenzo, et al.
Publicado: (2016)